AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team
AUAUniversity30 Apr 2025

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team CME Available: https://auau.auanet.org/node/42822 At the conclusion of this CME activity, participants will be able to: 1. Apply the mechanism of action of PARP inhibitors and the rationale for using them in patients with advanced prostate cancer. 2. Recognize the role and importance of genetic testing in patients with mCRPC and the implications of germline mutations on response to therapy. 3. Identify best practices and utilize available guidelines for patients with mCRPC to optimize treatment success and oncologic outcomes. 4. Recognize when to use PARP inhibitors as monotherapy, the rationale and indications for combination therapy, and appropriate treatment sequencing. 5. Successfully counsel patients on the possible adverse events associated with PARP inhibitor therapies alone or in combination. ACKOWLEDGEMENTS Support provided by independent educational grants from: AstraZeneca Merck & Co., Inc.

Episoder(422)

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
rss-strid-de-norske-borgerkrigene
foreldreradet
jakt-og-fiskepodden
rss-sunn-okonomi
merry-quizmas
smart-forklart
gravid-uke-for-uke
sinnsyn
fryktlos
hverdagspsyken
rss-mann-i-krise-med-sagen
rss-kunsten-a-leve
rss-adhd-i-klasserommet
aldring-og-helse-podden
dopet
diagnose